Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nature Reviews. Nephrology|September 19, 2012
STEC-HUS, atypical HUS and TTP are all diseases of complement activationMarina Noris, Federica Mescia, Giuseppe Remuzzi
Clinical Kidney Journal|September 5, 2023
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximabFederico Alberici, Federica Mescia, Francesco Scolari
Frontiers in Immunology|June 28, 2024
Treatment goals in ANCA-associated vasculitis: defining success in a new eraFederico Alberici, Martina Tedesco, Tamara Popov, et al.
Frontiers in Immunology|March 18, 2022
Therapies for Membranous Nephropathy: A Tale From the Old and New MillenniaFrancesco Scolari, Federico Alberici, Federica Mescia, et al.
Frontiers in Immunology|March 13, 2023
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectivesLuca Quartuccio, Elena Treppo, Livio Urso, et al.
Kidney International Reports|November 20, 2018
Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic PatientsJavier A Neyra, Federica Mescia, Xilong Li, et al.
Iscience|July 19, 2024
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVIDLisa Hurler, Federica Mescia, Laura Bergamaschi, et al.
Clinical Kidney Journal|February 26, 2024
Monoallelic pathogenic <i>IFT140</i> variants are a common cause of autosomal dominant polycystic kidney disease-spectrum phenotypeChiara Dordoni, Letizia Zeni, Diego Toso, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 21, 2024
Clinical Significance of the Cystic Phenotype in Alport SyndromeLetizia Zeni, Federica Mescia, Diego Toso, et al.
Pageof 4